Fourth MPXV IVD listed under the WHO Emergency Use Listing procedure
IVD
PQT/MED publishes first invitation to manufacturers of medicinal products for treatment of bacterial infections in children to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
M
A first invitation to manufacturers of medicinal products for treatment of bacterial infections in children, to submit an Expression of Interest (EOI) for product evaluation has been published by t
RV Lifesciences’ entecavir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
PQT/MED publishes first invitation to manufacturers of Mycobacterium tuberculosis antigen-based skin tests (TBSTs) to submit an Expression of Interest (EOI)
M
A first invitation to manufacturers of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), to submit an Expression of Interest (EOI) for product evaluation has been published by the WHO Pr
Active Pharmaceutical Ingredient (API) Prequalified
M
Albendazole (WHOAPI-427) manufactured by Sequent Scientific Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.